MANISH DESAI to Coronary Artery Disease
This is a "connection" page, showing publications MANISH DESAI has written about Coronary Artery Disease.
Connection Strength
0.603
-
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial. Lancet. 2025 04 26; 405(10488):1481-1490.
Score: 0.138
-
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial. Circulation. 2023 09 19; 148(12):950-958.
Score: 0.124
-
Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery. Circulation. 2022 05 31; 145(22):1655-1662.
Score: 0.112
-
ACIST-FFR Study (Assessment of Catheter-Based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement). Circ Cardiovasc Interv. 2017 Dec; 10(12).
Score: 0.083
-
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016 08; 90(2):411-421.
Score: 0.075
-
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Am Heart J. 2015 Oct; 170(4):619-626.e2.
Score: 0.070